BCL9L Blocking Peptide(N-term)
€363.00
In stock
SKU
AC-BP19875a
Background:
Transcriptional regulator that acts as an activator. Promotes beta-catenin transcriptional activity. Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1 (By similarity).
Other Names:
B-cell CLL/lymphoma 9-like protein, B-cell lymphoma 9-like protein, BCL9-like protein, Protein BCL9-2, BCL9L, DLNB11
Target/Specificity:
The synthetic peptide sequence is selected from aa 162-176 of HUMAN BCL9L
Gene Name: BCL9L
Gene ID: 283149
Primary Accession: Q86UU0
Other Accession: NP_872363.1
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Transcriptional regulator that acts as an activator. Promotes beta-catenin transcriptional activity. Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1 (By similarity).
Other Names:
B-cell CLL/lymphoma 9-like protein, B-cell lymphoma 9-like protein, BCL9-like protein, Protein BCL9-2, BCL9L, DLNB11
Target/Specificity:
The synthetic peptide sequence is selected from aa 162-176 of HUMAN BCL9L
Gene Name: BCL9L
Gene ID: 283149
Primary Accession: Q86UU0
Other Accession: NP_872363.1
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review